Shopping Cart
- Remove All
Your shopping cart is currently empty
PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $42 | In Stock | |
| 5 mg | $91 | In Stock | |
| 10 mg | $158 | In Stock | |
| 25 mg | $208 | In Stock | |
| 50 mg | $266 | In Stock | |
| 100 mg | $457 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $111 | In Stock |
| Description | PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. |
| In vivo | PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat[3]. |
| Synonyms | Danuglipron |
| Molecular Weight | 555.6 |
| Formula | C31H30FN5O4 |
| Cas No. | 2230198-02-2 |
| Smiles | OC(C1=CC=C(N=C(CN2CCC(C3=NC(OCC4=CC=C(C#N)C=C4F)=CC=C3)CC2)N5C[C@H]6OCC6)C5=C1)=O |
| Relative Density. | 1.39 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 125 mg/mL (224.98 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (7.2 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.